AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

 10,552.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 0
  • Market Cap: £163,625m
  • RiskGrade: 123

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
35.48% above the market average35.48% above the market average35.48% above the market average35.48% above the market average35.48% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
1yr Revenue Growth
52.91% above the market average52.91% above the market average52.91% above the market average52.91% above the market average52.91% above the market average
13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average13.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
45.24% below the market average45.24% below the market average45.24% below the market average45.24% below the market average45.24% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
1yr DPS Growth
24.61% above the market average24.61% above the market average24.61% above the market average24.61% above the market average24.61% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
81.1% below the market average81.1% below the market average81.1% below the market average81.1% below the market average81.1% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
14.32% above the market average14.32% above the market average14.32% above the market average14.32% above the market average14.32% above the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Price Chg 3m
64.91% below the market average64.91% below the market average64.91% below the market average64.91% below the market average64.91% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.21% above the market average11.21% above the market average11.21% above the market average11.21% above the market average11.21% above the market average
47.62% above the sector average47.62% above the sector average47.62% above the sector average47.62% above the sector average47.62% above the sector average
Momentum 20
90.98% above the market average90.98% above the market average90.98% above the market average90.98% above the market average90.98% above the market average
95.24% above the sector average95.24% above the sector average95.24% above the sector average95.24% above the sector average95.24% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
30.92% above the market average30.92% above the market average30.92% above the market average30.92% above the market average30.92% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
ROCE
75.84% above the market average75.84% above the market average75.84% above the market average75.84% above the market average75.84% above the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
99.40% above the market average99.40% above the market average99.40% above the market average99.40% above the market average99.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Forecast EPS
96.62% above the market average96.62% above the market average96.62% above the market average96.62% above the market average96.62% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
98.82% above the market average98.82% above the market average98.82% above the market average98.82% above the market average98.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Operating Profit Loss
98.97% above the market average98.97% above the market average98.97% above the market average98.97% above the market average98.97% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average97.67% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Cash
97.12% above the market average97.12% above the market average97.12% above the market average97.12% above the market average97.12% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
89.53% above the market average89.53% above the market average89.53% above the market average89.53% above the market average89.53% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
11.57% above the market average11.57% above the market average11.57% above the market average11.57% above the market average11.57% above the market average
37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average37.5% below the sector average
Brokers Percent Neutral
71.69% below the market average71.69% below the market average71.69% below the market average71.69% below the market average71.69% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,552.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 0
Shares Issued 1,550.66m
Market Cap £163,625m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.87% below the market average93.87% below the market average93.87% below the market average93.87% below the market average93.87% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Price Trend
20.53% below the market average20.53% below the market average20.53% below the market average20.53% below the market average20.53% below the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
62.31% below the market average62.31% below the market average62.31% below the market average62.31% below the market average62.31% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.28% above the market average86.28% above the market average86.28% above the market average86.28% above the market average86.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page